The Impact of COVID-19 Pandemic Response on Pediatric Mastoiditis-The Australian Experience.
文献摘要
Objective To assess the impact of COVID-19 pandemic response on the incidence and severity of pediatric mastoiditis in the Australian context. Study design Retrospective case series. Setting Single tertiary pediatric referral hospital in Australia. Methods Retrospective review of pediatric patients ( Results 176 patients were assessed. AM incidence per ED admissions sharply increased in the post-COVID era and exceeded pre-COVID levels. The proportion of patients with intracranial complications increased sharply over time. Mastoidectomy rates doubled from 13.43% (pre-COVID) to 28.40% (post-COVID). Streptococcus anginosus was associated with 100% mastoidectomy rate and very severe disease (80%). Patients in the postrestriction period had 3 times greater risk of very severe disease compared to prerestriction: 18.4% vs 6.0%, RR, 3.07 (95% CI, 1.1-8.6), P = .03. Conclusion An alarming increase in incidence and severity of pediatric AM in the postpandemic Australian population was identified. Vigilance of intracranial complications and rapid escalation of therapy are strongly recommended.